Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

NCT06238648

Conditions
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Siteman Cancer Center at Washington University St Louis, Missouri, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia

NCT06607419

Conditions
B-Cell Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Anhui Provincial Children's Hospital Hefei, Anhui, China
  • Fujian Children's Hospital Fuzhou, Fujian, China
  • Shanghai Children's Medical center Shanghai, Shanghai Municipality, China
  • Ningbo Women and Children's Hospital Ningbo, Zhejiang, China
View Trial Details
Recruiting

CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms

NCT06593145

Conditions
Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego - Centralny Szpital Kliniczny Warsaw, Ul. Banacha 1a, Poland
  • Uniwersyteckie Centrum Kliniczne Gdańskiego Uniwersytetu Medycznego - Katedra i Klinika Hematologii i Transplantologii Gdansk, Ul. Smoluchowskiego 17, Poland
View Trial Details
Recruiting

Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia

NCT06450067

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Recruiting

A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

NCT04332822

Conditions
DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations
  • Border Medical Oncology Research Unit Albury, Australia
  • Royal Prince Alfred Hospital Camperdown, Australia
  • Coffs Harbour Coffs Harbour, Australia
  • Concord Repatriation General Hospital Concord, Australia
View all 69 locations
View Trial Details
Recruiting

A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies

NCT03557619

Conditions
Disease Attributes, Hematologic Diseases, Hematologic Malignancies, +14 more
Locations
  • Duplicate_Henry Ford Health System /ID# 209090 Detroit, Michigan, United States
  • Dartmouth-Hitchcock Medical Center /ID# 169097 Lebanon, New Hampshire, United States
  • Gabrail Cancer Center Research /ID# 207039 Canton, Ohio, United States
  • Peter MacCallum Cancer Centre-East Melbourne /ID# 225247 East Melbourne, Victoria, Australia
View Trial Details

Related conditions